A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/06/2006	CN1872875A Anti-viral protein of ash tree flower, method of extraction, and application
12/06/2006	CN1872873A Function of cytoinhibition peptide for treating rheumatoid arthritis
12/06/2006	CN1872348A Ligand of polyoxyethylene of containing target peptide toward to liver cancer
12/06/2006	CN1872338A Chewing tablet for discharging lead, and preparation method
12/06/2006	CN1872337A Nasal cavity taking preparation of hirudin, and application
12/06/2006	CN1872336A Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
12/06/2006	CN1872335A Application of TRAP protein in preparing medicine for treating infection of staphylococcus aureus
12/06/2006	CN1872334A Slow releasing microsphere preparation of Thymopentin, and prepartion method
12/06/2006	CN1872333A Placenta factor, preparation method and application
12/06/2006	CN1288243C PEG-modified uricase
12/06/2006	CN1288165C A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
12/06/2006	CN1287856C An EPI-HNE protein dry powder
12/06/2006	CN1287855C Remedies for chronic hepatitis B
12/06/2006	CN1287854C Preparation method of NGF oral capsule
12/06/2006	CN1287853C Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway
12/06/2006	CN1287852C Drugs containing as active ingredient midkine or inhibitors thereof
12/06/2006	CN1287851C Ossotide sodium chloride injection and its preparing process
12/06/2006	CN1287850C Vaccines, immunotherapeutics and methods for using same
12/06/2006	CN1287789C Application of 15-fat oxidase inhibitor in preparing medicine for treating and preventing bone loss
12/06/2006	CN1287770C Pharmaceutical compositions in particulate form
12/06/2006	CN1287769C Dispersible phospholipid stabilzed microparticles
12/06/2006	CA2549663A1 Endoribonuclease and uses thereof
12/05/2006	US7144999 Modulation of hypoxia-inducible factor 1 alpha expression
12/05/2006	US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
12/05/2006	US7144994 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
12/05/2006	US7144992 Synergistic antimicrobial compositions and methods for reducing biofilm formation
12/05/2006	US7144989 Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
12/05/2006	US7144988 Rheumatic diseases; antiarthritic agents; osteoporosis; antiinflammatory agents; complex of protein and immunoglobulin; drug design; computer models
12/05/2006	US7144987 Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders
12/05/2006	US7144986 Prevent binding to immunoglobulins; genetic engineering; leukemia, antiproliferative agents, rheumatic diseases
12/05/2006	US7144985 Diagnosis of diabetes using antibody
12/05/2006	US7144984 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/05/2006	US7144983 mutants with multiple neurotrophic specificities; useful in the treatment of neuronal disorders; binds to trkB and other trk-tyrosine kinase receptors
12/05/2006	US7144982 Polypeptides with therapeutic activity and methods of use
12/05/2006	US7144902 Prodrugs of thrombin inhibitors
12/05/2006	US7144901 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
12/05/2006	US7144899 Thrombin inhibitors
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006	US7144892 Treatment of cardiovascular and related pathologies
12/05/2006	US7144880 Compositions relating to novel compounds and targets thereof
12/05/2006	US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof
12/05/2006	US7144877 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
12/05/2006	US7144865 Daily administering a mixture of zinc salt, cyclo-Hispro (soybean protein product), arachidonic acid; treating hypertension, high cholesterol, weight control; nutritional supplements, foods
12/05/2006	US7144864 Carboxypeptidase R inhibiting peptide
12/05/2006	US7144863 Powders of glucagon-like peptide is complexed with a polypeptide of polylysine, polyarginine, polyornithine, protamine, putrescine, spermine, spermidine, and histone; treating diabetes, hyperglycemia, obesity, irritable bowel syndrome, myocardial infarction; drug delivery by inhalation
12/05/2006	US7144862 Orally administered peptides to ameliorate atherosclerosis
12/05/2006	US7144861 Stabilized teriparatide solutions
12/05/2006	US7144860 Amd to ischemic tissue; treating atherosclerosis and restenosis.
12/05/2006	US7144859 Somatostatin agonists
12/05/2006	US7144858 Antibacterial compounds and methods for treating Gram positive bacterial infections
12/05/2006	US7144857 Vancomycin haemostatic paste composition
12/05/2006	US7144856 A salt of N-dipeptidoyl-O-acylhydroxyamines; suicide inhibitors which deactivate the DP I by the reaction with the nucleophilic active site thiol residue; inhibitors of the cysteine protease dipeptidyl peptidase I; cell degeneration, immune diseases impaired wound healing and metabolic diseases
12/05/2006	US7144855 Protein complex from ion-exchange chromatography for treatment of bacterial infections
12/05/2006	US7144854 Long lasting anti-angiogenic peptides
12/05/2006	US7144732 Vertebrate embryonic pattern-inducing proteins and uses related thereto
12/05/2006	US7144731 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells
12/05/2006	US7144729 Skin disorders; wound healing agents; antiscarring agents
12/05/2006	US7144721 Treatment of wounds
12/05/2006	US7144710 Method for detecting inflammation and inflammatory conditions
12/05/2006	US7144707 Determination of risk and treatment of complications of prematurity
12/05/2006	US7144704 Incubating mammalian cell expressing multidrug resistance gene or P-glycoprotein with immunological reagent specific for a biochemical conformation; evaluating binding; drug screening for anticarcinogenic agents
12/05/2006	US7144698 Postweaning multisystemic wasting syndrome virus from pigs
12/05/2006	US7144586 Compositions for preventing hormone induced adverse effects
12/05/2006	US7144581 Anticancer agents
12/05/2006	US7144580 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
12/05/2006	US7144577 Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
12/05/2006	US7144575 Methods for selectively stimulating proliferation of T cells
12/05/2006	US7144574 For therapy of multiple sclerosis
12/05/2006	CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/05/2006	CA2384929C A novel angiogenesis inhibitor
12/05/2006	CA2179183C Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
12/05/2006	CA2151945C Assay and treatment for demyelinating diseases such as multiple sclerosis
12/05/2006	CA2129921C Stable aqueous solutions of hybrid .alpha.-interferon bdbb
11/2006
11/30/2006	WO2006128196A2 Novel substrate for rpn 11 enzymatic activity
11/30/2006	WO2006128190A2 Compositions and methods for treatment of neural disorders using transforming growth factor-beta superfamily proteins and their antagonists
11/30/2006	WO2006128176A2 Composite molecules comprising g-csf function
11/30/2006	WO2006128131A2 Co-grafts for treating parkinson's disease
11/30/2006	WO2006128085A2 Cadherin-11-mediated modulation of hair growth
11/30/2006	WO2006128083A2 Human proislet peptide, derivatives and analogs thereof, and methods of using same
11/30/2006	WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides
11/30/2006	WO2006127978A2 Compositions and methods for the treatment of cancer
11/30/2006	WO2006127971A2 Broadband imager
11/30/2006	WO2006127966A2 Compositions and methods for enhancing axon regeneration
11/30/2006	WO2006127910A2 Glycopegylated erythropoietin formulations
11/30/2006	WO2006127907A2 Localized delivery of cardiac inotropic agents
11/30/2006	WO2006127896A2 Glycopegylated factor ix
11/30/2006	WO2006127822A2 Scytovirin domain 1 related polypeptides
11/30/2006	WO2006127761A1 Nutrition formulations and methods of providing nutrition formulations
11/30/2006	WO2006127715A1 Antimicrobial peptides
11/30/2006	WO2006127702A2 Analogs of glycyl-prolyl-glutamate
11/30/2006	WO2006127650A1 Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases
11/30/2006	WO2006127642A2 Use of botulinum toxin for treating peritoneal adhesions
11/30/2006	WO2006127452A2 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
11/30/2006	WO2006127361A2 Lipid construct for delivery of insulin to a mammal
11/30/2006	WO2006127360A2 Lipid construct for delivery of interferon to a mammal
11/30/2006	WO2006127289A1 Treatment of hcv with subtherapeutic doses of ribavirin
11/30/2006	WO2006127284A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold
11/30/2006	WO2006127214A1 Treating liver diseases
11/30/2006	WO2006126706A1 Prophylactic/therapeutic agent for psychotic disorder such as bipolar mood disorder and schizophrenia, screening method for the same, and method for determination of risk for the development of the disease
11/30/2006	WO2006126688A1 Agent for improvement of insulin resistance

1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 3163